Elon Musk, well-known businessman and CEO of Tesla y SpaceXsurprised his followers during the festivities by posting an image dressed as Santa Claus in which he admitted to using the drug Mounjaro as part of your weight loss strategy. This revelation was accompanied by a humorous comment on his social network, X. “Ozempic Santa… technically, Mounjaro, but it doesn’t sound the same,” the mogul wrote.
Mounjaro, whose main compound is in tirzepatibelongs to a class of medications known as GLP-1 inhibitorsoriginally developed to treat type 2 diabetesbut they have become popular for their effects on weight reduction.
According to Newsweekthe medicine has authorization from the United States Food and Drug Administration (FDA) from 2022 and, in addition, has the approval of the European Medicines Agency to help patients “lose weight and keep it under control” as part of a regimen complemented by diet and exercise.
“Mounjaro seems more effective to me and with fewer side effects,” admitted Musk, who also pointed out that in the past he used another medication of this type, Wegsand ruled out continuing with Ozempic due to adverse effects such as gas and indigestion.
In a publication on December 11, the magnate expressed his support for this type of drugs. “Nothing would do more to improve the health, life expectancy and quality of life of Americans than making them super low cost to the public,” he said.
GLP-1 drugs, such as Ozempic, Wegovy or Mounjaro, have taken a central role in debates about pharmacological options against obesity. Musk’s favorable stance towards these drugs contrasts with the vision of figures such as Robert F. Kennedy Jr.the designated secretary of Health and Human Services, who maintains that implementing healthier eating habits would be “a more cost-effective solution to combat the obesity crisis.”
Musk’s publication reiterates his position in favor of more widespread use of these medications. As he commented at the time, the magnate believes that confronting obesity with medical tools can be a viable way to solve public health problems in the United States, a position that has been supported even by liberal sectors traditionally critical of his ideas.
“Elon is right about this!” said the actress. Whoopi Goldberg during a recent episode of “The View,” a talk show where she also admitted to being a user of Mounjaro and proudly showed off her transformation after having lost a significant amount of weight.
At the same time, the businessman prepares to lead the Department of Government Efficiency (DOGE), a newly created body that will be part of the new presidential administration. This new office, driven in part by Musk, will seek to identify unnecessary regulations and propose structural savings measures to optimize public spending.
It should be noted that, although the billionaire remains dedicated to his technology companies, his influence within the political and public health scene seems to be gaining strength.
Experts have highlighted how the growing demand for medications like Mounjaro reflects a cultural and medical change in the treatment of overweight. According to the analysis of Newsweekpharmaceuticals like Eli Lilly (drug manufacturer) could play a crucial role in this scenario, given the rapidity with which such drugs are gaining ground outside their initial intended purpose for diabetic patients.
Musk’s Christmas post not only generated health-related comments, but also opened the door to discussions about how public figures influence perceptions of beauty and health. The Tesla CEO, who has openly stated that he does not like to exercise, exposes a cultural counterpoint by advocating for “practical remedies” like medications instead of more traditional endeavors like physical activity.
